Literature DB >> 35821738

Kidney Cancer Research Highlights from ASCO GU 2022 Meeting.

Yasser Ged1, Nirmish Singla1,2.   

Abstract

Entities:  

Year:  2022        PMID: 35821738      PMCID: PMC9272854          DOI: 10.52733/KCJ20n1-GU1

Source DB:  PubMed          Journal:  Kidney Cancer J        ISSN: 1933-0863


× No keyword cloud information.
  12 in total

Review 1.  Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.

Authors:  Laura S Schmidt; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2015-09-01       Impact factor: 14.432

2.  Distribution of metastatic sites in renal cell carcinoma: a population-based analysis.

Authors:  M Bianchi; M Sun; C Jeldres; S F Shariat; Q-D Trinh; A Briganti; Z Tian; J Schmitges; M Graefen; P Perrotte; M Menon; F Montorsi; P I Karakiewicz
Journal:  Ann Oncol       Date:  2011-09-02       Impact factor: 32.976

3.  Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.

Authors:  Toni K Choueiri; Piotr Tomczak; Se Hoon Park; Balaji Venugopal; Thomas Ferguson; Yen-Hwa Chang; Jaroslav Hajek; Stefan N Symeonides; Jae Lyun Lee; Naveed Sarwar; Antoine Thiery-Vuillemin; Marine Gross-Goupil; Mauricio Mahave; Naomi B Haas; Piotr Sawrycki; Howard Gurney; Christine Chevreau; Bohuslav Melichar; Evgeniy Kopyltsov; Ajjai Alva; John M Burke; Gurjyot Doshi; Delphine Topart; Stephane Oudard; Hans Hammers; Hiroshi Kitamura; Jens Bedke; Rodolfo F Perini; Pingye Zhang; Kentaro Imai; Jaqueline Willemann-Rogerio; David I Quinn; Thomas Powles
Journal:  N Engl J Med       Date:  2021-08-19       Impact factor: 91.245

4.  Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease.

Authors:  Jing Liu; Stephen J Blake; Michelle C R Yong; Heidi Harjunpää; Shin Foong Ngiow; Kazuyoshi Takeda; Arabella Young; Jake S O'Donnell; Stacey Allen; Mark J Smyth; Michele W L Teng
Journal:  Cancer Discov       Date:  2016-09-23       Impact factor: 39.397

5.  Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Authors:  Robert J Motzer; Konstantin Penkov; John Haanen; Brian Rini; Laurence Albiges; Matthew T Campbell; Balaji Venugopal; Christian Kollmannsberger; Sylvie Negrier; Motohide Uemura; Jae L Lee; Aleksandr Vasiliev; Wilson H Miller; Howard Gurney; Manuela Schmidinger; James Larkin; Michael B Atkins; Jens Bedke; Boris Alekseev; Jing Wang; Mariangela Mariani; Paul B Robbins; Aleksander Chudnovsky; Camilla Fowst; Subramanian Hariharan; Bo Huang; Alessandra di Pietro; Toni K Choueiri
Journal:  N Engl J Med       Date:  2019-02-16       Impact factor: 91.245

6.  The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?

Authors:  Hiten D Patel; Maneka Puligandla; Brian M Shuch; Bradley C Leibovich; Anil Kapoor; Viraj A Master; Charles G Drake; Daniel Yc Heng; Primo N Lara; Toni K Choueiri; Deborah Maskens; Eric A Singer; Scott E Eggener; Robert S Svatek; Walter M Stadler; Suzanne Cole; Sabina Signoretti; Rajan T Gupta; Marc Dror Michaelson; David F McDermott; David Cella; Lynne I Wagner; Naomi B Haas; Michael A Carducci; Lauren C Harshman; Mohamad E Allaf
Journal:  Future Oncol       Date:  2019-04-10       Impact factor: 3.404

7.  Pancreatic tropism of metastatic renal cell carcinoma.

Authors:  Nirmish Singla; Zhiqun Xie; Ze Zhang; Ming Gao; Qurratulain Yousuf; Oreoluwa Onabolu; Tiffani McKenzie; Vanina Toffessi Tcheuyap; Yuanqing Ma; Jacob Choi; Renee McKay; Alana Christie; Oscar Reig Torras; Isaac A Bowman; Vitaly Margulis; Ivan Pedrosa; Christopher Przybycin; Tao Wang; Payal Kapur; Brian Rini; James Brugarolas
Journal:  JCI Insight       Date:  2020-04-09

8.  Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.

Authors:  Samra Turajlic; Hang Xu; Kevin Litchfield; Andrew Rowan; Stuart Horswell; Tim Chambers; Tim O'Brien; Jose I Lopez; Thomas B K Watkins; David Nicol; Mark Stares; Ben Challacombe; Steve Hazell; Ashish Chandra; Thomas J Mitchell; Lewis Au; Claudia Eichler-Jonsson; Faiz Jabbar; Aspasia Soultati; Simon Chowdhury; Sarah Rudman; Joanna Lynch; Archana Fernando; Gordon Stamp; Emma Nye; Aengus Stewart; Wei Xing; Jonathan C Smith; Mickael Escudero; Adam Huffman; Nik Matthews; Greg Elgar; Ben Phillimore; Marta Costa; Sharmin Begum; Sophia Ward; Max Salm; Stefan Boeing; Rosalie Fisher; Lavinia Spain; Carolina Navas; Eva Grönroos; Sebastijan Hobor; Sarkhara Sharma; Ismaeel Aurangzeb; Sharanpreet Lall; Alexander Polson; Mary Varia; Catherine Horsfield; Nicos Fotiadis; Lisa Pickering; Roland F Schwarz; Bruno Silva; Javier Herrero; Nick M Luscombe; Mariam Jamal-Hanjani; Rachel Rosenthal; Nicolai J Birkbak; Gareth A Wilson; Orsolya Pipek; Dezso Ribli; Marcin Krzystanek; Istvan Csabai; Zoltan Szallasi; Martin Gore; Nicholas McGranahan; Peter Van Loo; Peter Campbell; James Larkin; Charles Swanton
Journal:  Cell       Date:  2018-04-12       Impact factor: 41.582

Review 9.  Novel emerging biomarkers to immunotherapy in kidney cancer.

Authors:  Yasser Ged; Martin H Voss
Journal:  Ther Adv Med Oncol       Date:  2021-11-25       Impact factor: 8.168

10.  Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade.

Authors:  Robert J Motzer; Romain Banchereau; Habib Hamidi; Thomas Powles; David McDermott; Michael B Atkins; Bernard Escudier; Li-Fen Liu; Ning Leng; Alexander R Abbas; Jinzhen Fan; Hartmut Koeppen; Jennifer Lin; Susheela Carroll; Kenji Hashimoto; Sanjeev Mariathasan; Marjorie Green; Darren Tayama; Priti S Hegde; Christina Schiff; Mahrukh A Huseni; Brian Rini
Journal:  Cancer Cell       Date:  2020-11-05       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.